🇺🇸 Conversion to extended-release tacrolimus in United States

Conversion to extended-release tacrolimus (Conversion to extended-release tacrolimus) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Conversion to extended-release tacrolimus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Conversion to extended-release tacrolimus approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Conversion to extended-release tacrolimus in United States?

Massachusetts General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.